Literature DB >> 6289066

Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes.

I Litosch, T H Hudson, I Mills, S Y Li, J N Fain.   

Abstract

Forskolin increased cyclic AMP accumulation in isolated adipocytes and markedly potentiated the elevation of cyclic AMP due to isoproterenol. In adipocyte membranes, forskolin stimulated adenylate cyclase activity at concentrations of 0.1 microM or greater. Forskolin did not affect the EC50 for activation of adenylate cyclase but did increase the maximal effect of isoproterenol. Neither the soluble nor particulate low-Km cyclic AMP phosphodiesterase activity was affected by forskolin. Low concentrations of forskolin (0.1-1.0 microM), which significantly elevated cyclic AMP levels, did not increase lipolysis, whereas similar increases in cyclic AMP levels due to isoproterenol elevated lipolysis. Forskolin did not inhibit the activation of triacylglycerol lipase by cyclic AMP-dependent protein kinase or the subsequent hydrolysis of triacylglycerol. Higher concentrations of forskolin (10-100 microM) did increase lipolysis. Both the increased cyclic AMP production and lipolysis due to forskolin were inhibited by the antilipolytic agents insulin and N6-(phenylisopropyl)adenosine. Hypothyroidism reduced the ability of forskolin to stimulate cyclic AMP production and lipolysis. These results indicate that forskolin increases cyclic AMP production in adipocytes through an activation of adenylate cyclase. Lipolysis is activated by forskolin but at higher concentrations of total cyclic AMP than for catecholamines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289066

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  29 in total

1.  Heat treatment induces an increase in intracellular cyclic AMP content in human epidermoid A-431 cells.

Authors:  J G Kiang; Y Y Wu; M C Lin
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

2.  Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.

Authors:  Isabelle Rauly-Lestienne; Elisa Boutet-Robinet; Marie-Christine Ailhaud; Adrian Newman-Tancredi; Didier Cussac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-05       Impact factor: 3.000

3.  Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes.

Authors:  A W Christie; D K McCormick; N Emmison; F B Kraemer; K G Alberti; S J Yeaman
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 4.  A review on botanical species and chemical compounds with appetite suppressing properties for body weight control.

Authors:  Katie J Astell; Michael L Mathai; Xiao Q Su
Journal:  Plant Foods Hum Nutr       Date:  2013-09       Impact factor: 3.921

5.  Evidence for a two-site model of forskolin action in frog urinary bladder.

Authors:  M Svelto; V Casavola; G Valenti; J Bourguet
Journal:  Pflugers Arch       Date:  1987-08       Impact factor: 3.657

6.  Relaxant effects of forskolin on guinea pig tracheal smooth muscle.

Authors:  M Tsukawaki; K Suzuki; R Suzuki; K Takagi; T Satake
Journal:  Lung       Date:  1987       Impact factor: 2.584

7.  Regulation of Na+/H+ exchange in opossum kidney cells by parathyroid hormone, cyclic AMP and phorbol esters.

Authors:  C Helmle-Kolb; M H Montrose; G Stange; H Murer
Journal:  Pflugers Arch       Date:  1990-01       Impact factor: 3.657

8.  Na+/H(+)-exchange in A6 cells: polarity and vasopressin regulation.

Authors:  V Casavola; L Guerra; C Helmle-Kolb; S J Reshkin; H Murer
Journal:  J Membr Biol       Date:  1992-11       Impact factor: 1.843

9.  Increasing cAMP attenuates activation of mitogen-activated protein kinase.

Authors:  B R Sevetson; X Kong; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  Effect of forskolin on islet cyclic AMP, insulin secretion, blood glucose and intravenous glucose tolerance in rats.

Authors:  H P Ammon; A B Müller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.